Global Lafutidine Tablets Market Growth 2026-2032

June 2026 | 94 pages | ID: G6BEF8CDC6BEEN
LP Information

Abstracts

The global Lafutidine Tablets market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.

United States market for Lafutidine Tablets is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

China market for Lafutidine Tablets is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Europe market for Lafutidine Tablets is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Global key Lafutidine Tablets players cover Jiangsu Runbang Pharmaceutical Co., Ltd., Chengdu Hengrui Pharmaceutical Co., Ltd., Sichuan Kelun Pharmaceutical Co., Ltd., Hubei Shubang Pharmaceutical Co., Ltd., Yuekang Pharmaceutical Group Co., Ltd., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.

LP Information, Inc. (LPI) ' newest research report, the ?Lafutidine Tablets Industry Forecast? looks at past sales and reviews total world Lafutidine Tablets sales in 2025, providing a comprehensive analysis by region and market sector of projected Lafutidine Tablets sales for 2026 through 2032. With Lafutidine Tablets sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Lafutidine Tablets industry.

This Insight Report provides a comprehensive analysis of the global Lafutidine Tablets landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Lafutidine Tablets portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Lafutidine Tablets market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Lafutidine Tablets and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Lafutidine Tablets.

This report presents a comprehensive overview, market shares, and growth opportunities of Lafutidine Tablets market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• 10mg
• 5mg

Segmentation by Application:

• Hospital
• Clinic
• Other

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• Jiangsu Runbang Pharmaceutical Co., Ltd.
• Chengdu Hengrui Pharmaceutical Co., Ltd.
• Sichuan Kelun Pharmaceutical Co., Ltd.
• Hubei Shubang Pharmaceutical Co., Ltd.
• Yuekang Pharmaceutical Group Co., Ltd.
• China Resources Double Crane Pharmaceutical Co., Ltd.
• Shandong Qidu Pharmaceutical Co., Ltd.

Key Questions Addressed in this Report
What is the 10-year outlook for the global Lafutidine Tablets market?
What factors are driving Lafutidine Tablets market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Lafutidine Tablets market opportunities vary by end market size?
How does Lafutidine Tablets break out by Type, by Application?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Lafutidine Tablets Annual Sales 2021-2032
  2.1.2 World Current & Future Analysis for Lafutidine Tablets by Geographic Region, 2021, 2025 & 2032
  2.1.3 World Current & Future Analysis for Lafutidine Tablets by Country/Region, 2021, 2025 & 2032
2.2 Lafutidine Tablets Segment by Type
  2.2.1 10mg
  2.2.2 5mg
  2.2.3 Lafutidine Tablets Sales by Type
    2.2.3.1 Global Lafutidine Tablets Sales Market Share by Type (2021-2026)
    2.2.3.2 Global Lafutidine Tablets Revenue and Market Share by Type (2021-2026)
    2.2.3.3 Global Lafutidine Tablets Sale Price by Type (2021-2026)
2.3 Lafutidine Tablets Segment by Application
  2.3.1 Hospital
  2.3.2 Clinic
  2.3.3 Other
  2.3.4 Lafutidine Tablets Sales by Application
    2.3.4.1 Global Lafutidine Tablets Sale Market Share by Application (2021-2026)
    2.3.4.2 Global Lafutidine Tablets Revenue and Market Share by Application (2021-2026)
    2.3.4.3 Global Lafutidine Tablets Sale Price by Application (2021-2026)

3 GLOBAL BY COMPANY

3.1 Global Lafutidine Tablets Breakdown Data by Company
  3.1.1 Global Lafutidine Tablets Annual Sales by Company (2021-2026)
  3.1.2 Global Lafutidine Tablets Sales Market Share by Company (2021-2026)
3.2 Global Lafutidine Tablets Annual Revenue by Company (2021-2026)
  3.2.1 Global Lafutidine Tablets Revenue by Company (2021-2026)
  3.2.2 Global Lafutidine Tablets Revenue Market Share by Company (2021-2026)
3.3 Global Lafutidine Tablets Sale Price by Company
3.4 Key Manufacturers Lafutidine Tablets Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Lafutidine Tablets Product Location Distribution
  3.4.2 Players Lafutidine Tablets Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR LAFUTIDINE TABLETS BY GEOGRAPHIC REGION

4.1 World Historic Lafutidine Tablets Market Size by Geographic Region (2021-2026)
  4.1.1 Global Lafutidine Tablets Annual Sales by Geographic Region (2021-2026)
  4.1.2 Global Lafutidine Tablets Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Lafutidine Tablets Market Size by Country/Region (2021-2026)
  4.2.1 Global Lafutidine Tablets Annual Sales by Country/Region (2021-2026)
  4.2.2 Global Lafutidine Tablets Annual Revenue by Country/Region (2021-2026)
4.3 Americas Lafutidine Tablets Sales Growth
4.4 APAC Lafutidine Tablets Sales Growth
4.5 Europe Lafutidine Tablets Sales Growth
4.6 Middle East & Africa Lafutidine Tablets Sales Growth

5 AMERICAS

5.1 Americas Lafutidine Tablets Sales by Country
  5.1.1 Americas Lafutidine Tablets Sales by Country (2021-2026)
  5.1.2 Americas Lafutidine Tablets Revenue by Country (2021-2026)
5.2 Americas Lafutidine Tablets Sales by Type (2021-2026)
5.3 Americas Lafutidine Tablets Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Lafutidine Tablets Sales by Region
  6.1.1 APAC Lafutidine Tablets Sales by Region (2021-2026)
  6.1.2 APAC Lafutidine Tablets Revenue by Region (2021-2026)
6.2 APAC Lafutidine Tablets Sales by Type (2021-2026)
6.3 APAC Lafutidine Tablets Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Lafutidine Tablets by Country
  7.1.1 Europe Lafutidine Tablets Sales by Country (2021-2026)
  7.1.2 Europe Lafutidine Tablets Revenue by Country (2021-2026)
7.2 Europe Lafutidine Tablets Sales by Type (2021-2026)
7.3 Europe Lafutidine Tablets Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Lafutidine Tablets by Country
  8.1.1 Middle East & Africa Lafutidine Tablets Sales by Country (2021-2026)
  8.1.2 Middle East & Africa Lafutidine Tablets Revenue by Country (2021-2026)
8.2 Middle East & Africa Lafutidine Tablets Sales by Type (2021-2026)
8.3 Middle East & Africa Lafutidine Tablets Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Lafutidine Tablets
10.3 Manufacturing Process Analysis of Lafutidine Tablets
10.4 Industry Chain Structure of Lafutidine Tablets

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Lafutidine Tablets Distributors
11.3 Lafutidine Tablets Customer

12 WORLD FORECAST REVIEW FOR LAFUTIDINE TABLETS BY GEOGRAPHIC REGION

12.1 Global Lafutidine Tablets Market Size Forecast by Region
  12.1.1 Global Lafutidine Tablets Forecast by Region (2027-2032)
  12.1.2 Global Lafutidine Tablets Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Lafutidine Tablets Forecast by Type (2027-2032)
12.7 Global Lafutidine Tablets Forecast by Application (2027-2032)

13 KEY PLAYERS ANALYSIS

13.1 Jiangsu Runbang Pharmaceutical Co., Ltd.
  13.1.1 Jiangsu Runbang Pharmaceutical Co., Ltd. Company Information
  13.1.2 Jiangsu Runbang Pharmaceutical Co., Ltd. Lafutidine Tablets Product Portfolios and Specifications
  13.1.3 Jiangsu Runbang Pharmaceutical Co., Ltd. Lafutidine Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  13.1.4 Jiangsu Runbang Pharmaceutical Co., Ltd. Main Business Overview
  13.1.5 Jiangsu Runbang Pharmaceutical Co., Ltd. Latest Developments
13.2 Chengdu Hengrui Pharmaceutical Co., Ltd.
  13.2.1 Chengdu Hengrui Pharmaceutical Co., Ltd. Company Information
  13.2.2 Chengdu Hengrui Pharmaceutical Co., Ltd. Lafutidine Tablets Product Portfolios and Specifications
  13.2.3 Chengdu Hengrui Pharmaceutical Co., Ltd. Lafutidine Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  13.2.4 Chengdu Hengrui Pharmaceutical Co., Ltd. Main Business Overview
  13.2.5 Chengdu Hengrui Pharmaceutical Co., Ltd. Latest Developments
13.3 Sichuan Kelun Pharmaceutical Co., Ltd.
  13.3.1 Sichuan Kelun Pharmaceutical Co., Ltd. Company Information
  13.3.2 Sichuan Kelun Pharmaceutical Co., Ltd. Lafutidine Tablets Product Portfolios and Specifications
  13.3.3 Sichuan Kelun Pharmaceutical Co., Ltd. Lafutidine Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  13.3.4 Sichuan Kelun Pharmaceutical Co., Ltd. Main Business Overview
  13.3.5 Sichuan Kelun Pharmaceutical Co., Ltd. Latest Developments
13.4 Hubei Shubang Pharmaceutical Co., Ltd.
  13.4.1 Hubei Shubang Pharmaceutical Co., Ltd. Company Information
  13.4.2 Hubei Shubang Pharmaceutical Co., Ltd. Lafutidine Tablets Product Portfolios and Specifications
  13.4.3 Hubei Shubang Pharmaceutical Co., Ltd. Lafutidine Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  13.4.4 Hubei Shubang Pharmaceutical Co., Ltd. Main Business Overview
  13.4.5 Hubei Shubang Pharmaceutical Co., Ltd. Latest Developments
13.5 Yuekang Pharmaceutical Group Co., Ltd.
  13.5.1 Yuekang Pharmaceutical Group Co., Ltd. Company Information
  13.5.2 Yuekang Pharmaceutical Group Co., Ltd. Lafutidine Tablets Product Portfolios and Specifications
  13.5.3 Yuekang Pharmaceutical Group Co., Ltd. Lafutidine Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  13.5.4 Yuekang Pharmaceutical Group Co., Ltd. Main Business Overview
  13.5.5 Yuekang Pharmaceutical Group Co., Ltd. Latest Developments
13.6 China Resources Double Crane Pharmaceutical Co., Ltd.
  13.6.1 China Resources Double Crane Pharmaceutical Co., Ltd. Company Information
  13.6.2 China Resources Double Crane Pharmaceutical Co., Ltd. Lafutidine Tablets Product Portfolios and Specifications
  13.6.3 China Resources Double Crane Pharmaceutical Co., Ltd. Lafutidine Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  13.6.4 China Resources Double Crane Pharmaceutical Co., Ltd. Main Business Overview
  13.6.5 China Resources Double Crane Pharmaceutical Co., Ltd. Latest Developments
13.7 Shandong Qidu Pharmaceutical Co., Ltd.
  13.7.1 Shandong Qidu Pharmaceutical Co., Ltd. Company Information
  13.7.2 Shandong Qidu Pharmaceutical Co., Ltd. Lafutidine Tablets Product Portfolios and Specifications
  13.7.3 Shandong Qidu Pharmaceutical Co., Ltd. Lafutidine Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  13.7.4 Shandong Qidu Pharmaceutical Co., Ltd. Main Business Overview
  13.7.5 Shandong Qidu Pharmaceutical Co., Ltd. Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. LafutidineTablets Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. LafutidineTablets Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of 10mg
Table 4. Major Players of 5mg
Table 5. Global LafutidineTablets Sales by Type (2021-2026) & (K Units)
Table 6. Global LafutidineTablets Sales Market Share by Type (2021-2026)
Table 7. Global LafutidineTablets Revenue by Type (2021-2026) & ($ million)
Table 8. Global LafutidineTablets Revenue Market Share by Type (2021-2026)
Table 9. Global LafutidineTablets Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global LafutidineTablets Sale by Application (2021-2026) & (K Units)
Table 11. Global LafutidineTablets Sale Market Share by Application (2021-2026)
Table 12. Global LafutidineTablets Revenue by Application (2021-2026) & ($ million)
Table 13. Global LafutidineTablets Revenue Market Share by Application (2021-2026)
Table 14. Global LafutidineTablets Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global LafutidineTablets Sales by Company (2021-2026) & (K Units)
Table 16. Global LafutidineTablets Sales Market Share by Company (2021-2026)
Table 17. Global LafutidineTablets Revenue by Company (2021-2026) & ($ millions)
Table 18. Global LafutidineTablets Revenue Market Share by Company (2021-2026)
Table 19. Global LafutidineTablets Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers LafutidineTablets Producing Area Distribution and Sales Area
Table 21. Players LafutidineTablets Products Offered
Table 22. LafutidineTablets Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global LafutidineTablets Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global LafutidineTablets Sales Market Share Geographic Region (2021-2026)
Table 27. Global LafutidineTablets Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global LafutidineTablets Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global LafutidineTablets Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global LafutidineTablets Sales Market Share by Country/Region (2021-2026)
Table 31. Global LafutidineTablets Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global LafutidineTablets Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas LafutidineTablets Sales by Country (2021-2026) & (K Units)
Table 34. Americas LafutidineTablets Sales Market Share by Country (2021-2026)
Table 35. Americas LafutidineTablets Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas LafutidineTablets Sales by Type (2021-2026) & (K Units)
Table 37. Americas LafutidineTablets Sales by Application (2021-2026) & (K Units)
Table 38. APAC LafutidineTablets Sales by Region (2021-2026) & (K Units)
Table 39. APAC LafutidineTablets Sales Market Share by Region (2021-2026)
Table 40. APAC LafutidineTablets Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC LafutidineTablets Sales by Type (2021-2026) & (K Units)
Table 42. APAC LafutidineTablets Sales by Application (2021-2026) & (K Units)
Table 43. Europe LafutidineTablets Sales by Country (2021-2026) & (K Units)
Table 44. Europe LafutidineTablets Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe LafutidineTablets Sales by Type (2021-2026) & (K Units)
Table 46. Europe LafutidineTablets Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa LafutidineTablets Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa LafutidineTablets Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa LafutidineTablets Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa LafutidineTablets Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of LafutidineTablets
Table 52. Key Market Challenges & Risks of LafutidineTablets
Table 53. Key Industry Trends of LafutidineTablets
Table 54. LafutidineTablets Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. LafutidineTablets Distributors List
Table 57. LafutidineTablets Customer List
Table 58. Global LafutidineTablets Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global LafutidineTablets Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas LafutidineTablets Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas LafutidineTablets Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC LafutidineTablets Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC LafutidineTablets Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe LafutidineTablets Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe LafutidineTablets Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa LafutidineTablets Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa LafutidineTablets Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global LafutidineTablets Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global LafutidineTablets Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global LafutidineTablets Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global LafutidineTablets Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Jiangsu Runbang Pharmaceutical Co., Ltd. Basic Information, LafutidineTablets Manufacturing Base, Sales Area and Its Competitors
Table 73. Jiangsu Runbang Pharmaceutical Co., Ltd. LafutidineTablets Product Portfolios and Specifications
Table 74. Jiangsu Runbang Pharmaceutical Co., Ltd. LafutidineTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Jiangsu Runbang Pharmaceutical Co., Ltd. Main Business
Table 76. Jiangsu Runbang Pharmaceutical Co., Ltd. Latest Developments
Table 77. Chengdu Hengrui Pharmaceutical Co., Ltd. Basic Information, LafutidineTablets Manufacturing Base, Sales Area and Its Competitors
Table 78. Chengdu Hengrui Pharmaceutical Co., Ltd. LafutidineTablets Product Portfolios and Specifications
Table 79. Chengdu Hengrui Pharmaceutical Co., Ltd. LafutidineTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. Chengdu Hengrui Pharmaceutical Co., Ltd. Main Business
Table 81. Chengdu Hengrui Pharmaceutical Co., Ltd. Latest Developments
Table 82. Sichuan Kelun Pharmaceutical Co., Ltd. Basic Information, LafutidineTablets Manufacturing Base, Sales Area and Its Competitors
Table 83. Sichuan Kelun Pharmaceutical Co., Ltd. LafutidineTablets Product Portfolios and Specifications
Table 84. Sichuan Kelun Pharmaceutical Co., Ltd. LafutidineTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. Sichuan Kelun Pharmaceutical Co., Ltd. Main Business
Table 86. Sichuan Kelun Pharmaceutical Co., Ltd. Latest Developments
Table 87. Hubei Shubang Pharmaceutical Co., Ltd. Basic Information, LafutidineTablets Manufacturing Base, Sales Area and Its Competitors
Table 88. Hubei Shubang Pharmaceutical Co., Ltd. LafutidineTablets Product Portfolios and Specifications
Table 89. Hubei Shubang Pharmaceutical Co., Ltd. LafutidineTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Hubei Shubang Pharmaceutical Co., Ltd. Main Business
Table 91. Hubei Shubang Pharmaceutical Co., Ltd. Latest Developments
Table 92. Yuekang Pharmaceutical Group Co., Ltd. Basic Information, LafutidineTablets Manufacturing Base, Sales Area and Its Competitors
Table 93. Yuekang Pharmaceutical Group Co., Ltd. LafutidineTablets Product Portfolios and Specifications
Table 94. Yuekang Pharmaceutical Group Co., Ltd. LafutidineTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Yuekang Pharmaceutical Group Co., Ltd. Main Business
Table 96. Yuekang Pharmaceutical Group Co., Ltd. Latest Developments
Table 97. China Resources Double Crane Pharmaceutical Co., Ltd. Basic Information, LafutidineTablets Manufacturing Base, Sales Area and Its Competitors
Table 98. China Resources Double Crane Pharmaceutical Co., Ltd. LafutidineTablets Product Portfolios and Specifications
Table 99. China Resources Double Crane Pharmaceutical Co., Ltd. LafutidineTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. China Resources Double Crane Pharmaceutical Co., Ltd. Main Business
Table 101. China Resources Double Crane Pharmaceutical Co., Ltd. Latest Developments
Table 102. Shandong Qidu Pharmaceutical Co., Ltd. Basic Information, LafutidineTablets Manufacturing Base, Sales Area and Its Competitors
Table 103. Shandong Qidu Pharmaceutical Co., Ltd. LafutidineTablets Product Portfolios and Specifications
Table 104. Shandong Qidu Pharmaceutical Co., Ltd. LafutidineTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. Shandong Qidu Pharmaceutical Co., Ltd. Main Business
Table 106. Shandong Qidu Pharmaceutical Co., Ltd. Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of LafutidineTablets
Figure 2. LafutidineTablets Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global LafutidineTablets Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global LafutidineTablets Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. LafutidineTablets Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. LafutidineTablets Sales Market Share by Country/Region (2025)
Figure 10. LafutidineTablets Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of 10mg
Figure 12. Product Picture of 5mg
Figure 13. Global LafutidineTablets Sales Market Share by Type in 2026
Figure 14. Global LafutidineTablets Revenue Market Share by Type (2021-2026)
Figure 15. LafutidineTablets Consumed in Hospital
Figure 16. Global LafutidineTablets Market: Hospital (2021-2026) & (K Units)
Figure 17. LafutidineTablets Consumed in Clinic
Figure 18. Global LafutidineTablets Market: Clinic (2021-2026) & (K Units)
Figure 19. LafutidineTablets Consumed in Other
Figure 20. Global LafutidineTablets Market: Other (2021-2026) & (K Units)
Figure 21. Global LafutidineTablets Sale Market Share by Application (2025)
Figure 22. Global LafutidineTablets Revenue Market Share by Application in 2026
Figure 23. LafutidineTablets Sales by Company in 2026 (K Units)
Figure 24. Global LafutidineTablets Sales Market Share by Company in 2026
Figure 25. LafutidineTablets Revenue by Company in 2026 ($ millions)
Figure 26. Global LafutidineTablets Revenue Market Share by Company in 2026
Figure 27. Global LafutidineTablets Sales Market Share by Geographic Region (2021-2026)
Figure 28. Global LafutidineTablets Revenue Market Share by Geographic Region in 2026
Figure 29. Americas LafutidineTablets Sales 2021-2026 (K Units)
Figure 30. Americas LafutidineTablets Revenue 2021-2026 ($ millions)
Figure 31. APAC LafutidineTablets Sales 2021-2026 (K Units)
Figure 32. APAC LafutidineTablets Revenue 2021-2026 ($ millions)
Figure 33. Europe LafutidineTablets Sales 2021-2026 (K Units)
Figure 34. Europe LafutidineTablets Revenue 2021-2026 ($ millions)
Figure 35. Middle East & Africa LafutidineTablets Sales 2021-2026 (K Units)
Figure 36. Middle East & Africa LafutidineTablets Revenue 2021-2026 ($ millions)
Figure 37. Americas LafutidineTablets Sales Market Share by Country in 2026
Figure 38. Americas LafutidineTablets Revenue Market Share by Country (2021-2026)
Figure 39. Americas LafutidineTablets Sales Market Share by Type (2021-2026)
Figure 40. Americas LafutidineTablets Sales Market Share by Application (2021-2026)
Figure 41. United States LafutidineTablets Revenue Growth 2021-2026 ($ millions)
Figure 42. Canada LafutidineTablets Revenue Growth 2021-2026 ($ millions)
Figure 43. Mexico LafutidineTablets Revenue Growth 2021-2026 ($ millions)
Figure 44. Brazil LafutidineTablets Revenue Growth 2021-2026 ($ millions)
Figure 45. APAC LafutidineTablets Sales Market Share by Region in 2026
Figure 46. APAC LafutidineTablets Revenue Market Share by Region (2021-2026)
Figure 47. APAC LafutidineTablets Sales Market Share by Type (2021-2026)
Figure 48. APAC LafutidineTablets Sales Market Share by Application (2021-2026)
Figure 49. China LafutidineTablets Revenue Growth 2021-2026 ($ millions)
Figure 50. Japan LafutidineTablets Revenue Growth 2021-2026 ($ millions)
Figure 51. South Korea LafutidineTablets Revenue Growth 2021-2026 ($ millions)
Figure 52. Southeast Asia LafutidineTablets Revenue Growth 2021-2026 ($ millions)
Figure 53. India LafutidineTablets Revenue Growth 2021-2026 ($ millions)
Figure 54. Australia LafutidineTablets Revenue Growth 2021-2026 ($ millions)
Figure 55. China Taiwan LafutidineTablets Revenue Growth 2021-2026 ($ millions)
Figure 56. Europe LafutidineTablets Sales Market Share by Country in 2026
Figure 57. Europe LafutidineTablets Revenue Market Share by Country (2021-2026)
Figure 58. Europe LafutidineTablets Sales Market Share by Type (2021-2026)
Figure 59. Europe LafutidineTablets Sales Market Share by Application (2021-2026)
Figure 60. Germany LafutidineTablets Revenue Growth 2021-2026 ($ millions)
Figure 61. France LafutidineTablets Revenue Growth 2021-2026 ($ millions)
Figure 62. UK LafutidineTablets Revenue Growth 2021-2026 ($ millions)
Figure 63. Italy LafutidineTablets Revenue Growth 2021-2026 ($ millions)
Figure 64. Russia LafutidineTablets Revenue Growth 2021-2026 ($ millions)
Figure 65. Middle East & Africa LafutidineTablets Sales Market Share by Country (2021-2026)
Figure 66. Middle East & Africa LafutidineTablets Sales Market Share by Type (2021-2026)
Figure 67. Middle East & Africa LafutidineTablets Sales Market Share by Application (2021-2026)
Figure 68. Egypt LafutidineTablets Revenue Growth 2021-2026 ($ millions)
Figure 69. South Africa LafutidineTablets Revenue Growth 2021-2026 ($ millions)
Figure 70. Israel LafutidineTablets Revenue Growth 2021-2026 ($ millions)
Figure 71. Turkey LafutidineTablets Revenue Growth 2021-2026 ($ millions)
Figure 72. GCC Countries LafutidineTablets Revenue Growth 2021-2026 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of LafutidineTablets in 2026
Figure 74. Manufacturing Process Analysis of LafutidineTablets
Figure 75. Industry Chain Structure of LafutidineTablets
Figure 76. Channels of Distribution
Figure 77. Global LafutidineTablets Sales Market Forecast by Region (2027-2032)
Figure 78. Global LafutidineTablets Revenue Market Share Forecast by Region (2027-2032)
Figure 79. Global LafutidineTablets Sales Market Share Forecast by Type (2027-2032)
Figure 80. Global LafutidineTablets Revenue Market Share Forecast by Type (2027-2032)
Figure 81. Global LafutidineTablets Sales Market Share Forecast by Application (2027-2032)
Figure 82. Global LafutidineTablets Revenue Market Share Forecast by Application (2027-2032)